A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease

James A. Timmons, Philip J. Atherton, Ola Larsson, Sanjana Sood, Ilya O. Blokhin, Robert J. Brogan, Claude Henry Volmar, Andrea R. Josse, Cris Slentz, Claes R Wahlestedt, Stuart M. Phillips, Bethan E. Phillips, Iain J. Gallagher, William E. Kraus

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Genome-wide association studies (GWAS), relying on hundreds of thousands of individuals, have revealed >200 genomic loci linked to metabolic disease (MD). Loss of insulin sensitivity (IS) is a key component of MD and we hypothesized that discovery of a robust IS transcriptome would help reveal the underlying genomic structure of MD. Using 1,012 human skeletal muscle samples, detailed physiology and a tissue-optimized approach for the quantification of coding (>18,000) and non-coding (>15,000) RNA (ncRNA), we identified 332 fasting IS-related genes (CORE-IS). Over 200 had a proven role in the biochemistry of insulin and/or metabolism or were located at GWAS MD loci. Over 50% of the CORE-IS genes responded to clinical treatment; 16 quantitatively tracking changes in IS across four independent studies (P = 0.0000053: negatively: AGL, G0S2, KPNA2, PGM2, RND3 and TSPAN9 and positively: ALDH6A1, DHTKD1, ECHDC3, MCCC1, OARD1, PCYT2, PRRX1, SGCG, SLC43A1 and SMIM8). A network of ncRNA positively related to IS and interacted with RNA coding for viral response proteins (P < 1 × 10−48), while reduced amino acid catabolic gene expression occurred without a change in expression of oxidative-phosphorylation genes. We illustrate that combining in-depth physiological phenotyping with robust RNA profiling methods, identifies molecular networks which are highly consistent with the genetics and biochemistry of human metabolic disease.

Original languageEnglish (US)
Pages (from-to)7772-7792
Number of pages21
JournalNucleic Acids Research
Volume46
Issue number15
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Metabolic Diseases
Genomics
Insulin Resistance
Genome-Wide Association Study
RNA
Biochemistry
Genes
Oxidative Phosphorylation
Medical Genetics
Viral Proteins
Transcriptome
Fasting
Skeletal Muscle
Insulin
Gene Expression
Amino Acids

ASJC Scopus subject areas

  • Genetics

Cite this

Timmons, J. A., Atherton, P. J., Larsson, O., Sood, S., Blokhin, I. O., Brogan, R. J., ... Kraus, W. E. (2018). A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease. Nucleic Acids Research, 46(15), 7772-7792. https://doi.org/10.1093/nar/gky570

A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease. / Timmons, James A.; Atherton, Philip J.; Larsson, Ola; Sood, Sanjana; Blokhin, Ilya O.; Brogan, Robert J.; Volmar, Claude Henry; Josse, Andrea R.; Slentz, Cris; Wahlestedt, Claes R; Phillips, Stuart M.; Phillips, Bethan E.; Gallagher, Iain J.; Kraus, William E.

In: Nucleic Acids Research, Vol. 46, No. 15, 01.01.2018, p. 7772-7792.

Research output: Contribution to journalArticle

Timmons, JA, Atherton, PJ, Larsson, O, Sood, S, Blokhin, IO, Brogan, RJ, Volmar, CH, Josse, AR, Slentz, C, Wahlestedt, CR, Phillips, SM, Phillips, BE, Gallagher, IJ & Kraus, WE 2018, 'A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease', Nucleic Acids Research, vol. 46, no. 15, pp. 7772-7792. https://doi.org/10.1093/nar/gky570
Timmons JA, Atherton PJ, Larsson O, Sood S, Blokhin IO, Brogan RJ et al. A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease. Nucleic Acids Research. 2018 Jan 1;46(15):7772-7792. https://doi.org/10.1093/nar/gky570
Timmons, James A. ; Atherton, Philip J. ; Larsson, Ola ; Sood, Sanjana ; Blokhin, Ilya O. ; Brogan, Robert J. ; Volmar, Claude Henry ; Josse, Andrea R. ; Slentz, Cris ; Wahlestedt, Claes R ; Phillips, Stuart M. ; Phillips, Bethan E. ; Gallagher, Iain J. ; Kraus, William E. / A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease. In: Nucleic Acids Research. 2018 ; Vol. 46, No. 15. pp. 7772-7792.
@article{7e1f85b6bf4641f39bbc212b3fefdd7f,
title = "A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease",
abstract = "Genome-wide association studies (GWAS), relying on hundreds of thousands of individuals, have revealed >200 genomic loci linked to metabolic disease (MD). Loss of insulin sensitivity (IS) is a key component of MD and we hypothesized that discovery of a robust IS transcriptome would help reveal the underlying genomic structure of MD. Using 1,012 human skeletal muscle samples, detailed physiology and a tissue-optimized approach for the quantification of coding (>18,000) and non-coding (>15,000) RNA (ncRNA), we identified 332 fasting IS-related genes (CORE-IS). Over 200 had a proven role in the biochemistry of insulin and/or metabolism or were located at GWAS MD loci. Over 50{\%} of the CORE-IS genes responded to clinical treatment; 16 quantitatively tracking changes in IS across four independent studies (P = 0.0000053: negatively: AGL, G0S2, KPNA2, PGM2, RND3 and TSPAN9 and positively: ALDH6A1, DHTKD1, ECHDC3, MCCC1, OARD1, PCYT2, PRRX1, SGCG, SLC43A1 and SMIM8). A network of ncRNA positively related to IS and interacted with RNA coding for viral response proteins (P < 1 × 10−48), while reduced amino acid catabolic gene expression occurred without a change in expression of oxidative-phosphorylation genes. We illustrate that combining in-depth physiological phenotyping with robust RNA profiling methods, identifies molecular networks which are highly consistent with the genetics and biochemistry of human metabolic disease.",
author = "Timmons, {James A.} and Atherton, {Philip J.} and Ola Larsson and Sanjana Sood and Blokhin, {Ilya O.} and Brogan, {Robert J.} and Volmar, {Claude Henry} and Josse, {Andrea R.} and Cris Slentz and Wahlestedt, {Claes R} and Phillips, {Stuart M.} and Phillips, {Bethan E.} and Gallagher, {Iain J.} and Kraus, {William E.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1093/nar/gky570",
language = "English (US)",
volume = "46",
pages = "7772--7792",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "15",

}

TY - JOUR

T1 - A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease

AU - Timmons, James A.

AU - Atherton, Philip J.

AU - Larsson, Ola

AU - Sood, Sanjana

AU - Blokhin, Ilya O.

AU - Brogan, Robert J.

AU - Volmar, Claude Henry

AU - Josse, Andrea R.

AU - Slentz, Cris

AU - Wahlestedt, Claes R

AU - Phillips, Stuart M.

AU - Phillips, Bethan E.

AU - Gallagher, Iain J.

AU - Kraus, William E.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Genome-wide association studies (GWAS), relying on hundreds of thousands of individuals, have revealed >200 genomic loci linked to metabolic disease (MD). Loss of insulin sensitivity (IS) is a key component of MD and we hypothesized that discovery of a robust IS transcriptome would help reveal the underlying genomic structure of MD. Using 1,012 human skeletal muscle samples, detailed physiology and a tissue-optimized approach for the quantification of coding (>18,000) and non-coding (>15,000) RNA (ncRNA), we identified 332 fasting IS-related genes (CORE-IS). Over 200 had a proven role in the biochemistry of insulin and/or metabolism or were located at GWAS MD loci. Over 50% of the CORE-IS genes responded to clinical treatment; 16 quantitatively tracking changes in IS across four independent studies (P = 0.0000053: negatively: AGL, G0S2, KPNA2, PGM2, RND3 and TSPAN9 and positively: ALDH6A1, DHTKD1, ECHDC3, MCCC1, OARD1, PCYT2, PRRX1, SGCG, SLC43A1 and SMIM8). A network of ncRNA positively related to IS and interacted with RNA coding for viral response proteins (P < 1 × 10−48), while reduced amino acid catabolic gene expression occurred without a change in expression of oxidative-phosphorylation genes. We illustrate that combining in-depth physiological phenotyping with robust RNA profiling methods, identifies molecular networks which are highly consistent with the genetics and biochemistry of human metabolic disease.

AB - Genome-wide association studies (GWAS), relying on hundreds of thousands of individuals, have revealed >200 genomic loci linked to metabolic disease (MD). Loss of insulin sensitivity (IS) is a key component of MD and we hypothesized that discovery of a robust IS transcriptome would help reveal the underlying genomic structure of MD. Using 1,012 human skeletal muscle samples, detailed physiology and a tissue-optimized approach for the quantification of coding (>18,000) and non-coding (>15,000) RNA (ncRNA), we identified 332 fasting IS-related genes (CORE-IS). Over 200 had a proven role in the biochemistry of insulin and/or metabolism or were located at GWAS MD loci. Over 50% of the CORE-IS genes responded to clinical treatment; 16 quantitatively tracking changes in IS across four independent studies (P = 0.0000053: negatively: AGL, G0S2, KPNA2, PGM2, RND3 and TSPAN9 and positively: ALDH6A1, DHTKD1, ECHDC3, MCCC1, OARD1, PCYT2, PRRX1, SGCG, SLC43A1 and SMIM8). A network of ncRNA positively related to IS and interacted with RNA coding for viral response proteins (P < 1 × 10−48), while reduced amino acid catabolic gene expression occurred without a change in expression of oxidative-phosphorylation genes. We illustrate that combining in-depth physiological phenotyping with robust RNA profiling methods, identifies molecular networks which are highly consistent with the genetics and biochemistry of human metabolic disease.

UR - http://www.scopus.com/inward/record.url?scp=85055425956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055425956&partnerID=8YFLogxK

U2 - 10.1093/nar/gky570

DO - 10.1093/nar/gky570

M3 - Article

VL - 46

SP - 7772

EP - 7792

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 15

ER -